Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Stockholders' Equity (Unaudited)

v3.19.3
Condensed Consolidated Statements of Stockholders' Equity (Unaudited) - USD ($)
Series A Convertible Preferred Stock [Member]
Series A Convertible Preferred Stock Subscribed But Not Issued [Member]
Common Stock [Member]
Common Stock Subscribed But Not Issued [Member]
Additional Paid-In Capital [Member]
Accumulated Deficit [Member]
Non-Controlling Interests [Member]
Total
Balance at Dec. 31, 2017 $ 500 $ 176,850 $ 370,000 $ 22,256,060 $ (11,971,740) $ 175,490 $ 11,007,160
Balance, shares at Dec. 31, 2017 500,000 176,850,331 1,000,000        
Sales of common stock $ 14,190 16,881,810 16,896,000
Sales of common stock, shares 14,189,738        
Conversion of Series A preferred stock $ (500) $ 971 33,573 34,044
Conversion of Series A preferred stock, shares (500,000) 970,988        
Issuance of subscribed shares $ 1,000 $ (370,000) 369,000
Issuance of subscribed shares, shares 1,000,000 (1,000,000)        
iRollie acquisition $ 600,000 600,000
iRollie acquisition, shares 264,317        
Settlement of obligations $ 3,368 $ 10,000 3,627,253 3,640,621
Settlement of obligations, shares 3,367,632 2,894        
Conversion of membership interest $ 222 (222)
Conversion of membership interest, shares 222,222          
Exercise of options $ 602 38,398 $ 39,000
Exercise of options, shares   602,000       400,000
Exercise of warrants $ 1,900 210,384 $ 212,284
Exercise of warrants, shares 1,899,934        
Retirement of promissory notes $ 4,019 $ 3,250,000 8,474,786 11,728,805
Retirement of promissory notes, shares 4,018,534 1,231,060        
Distributions (507,453) (507,453)
Amortization of stock grants              
Amortization of option grants 1,023,300 1,023,300
Amortization of stand-alone warrant issuances 1,351,762
Warrant discount on promissory notes 1,709,596
Net income (loss) (5,859,985) 223,882 (5,636,103)
Balance at Sep. 30, 2018 $ 203,122 $ 3,860,000 55,975,700 (17,831,725) (108,081) 42,099,016
Balance, shares at Sep. 30, 2018 203,121,379 1,498,271        
Balance at Dec. 31, 2017 $ 500 $ 176,850 $ 370,000 22,256,060 (11,971,740) 175,490 11,007,160
Balance, shares at Dec. 31, 2017 500,000 176,850,331 1,000,000        
Balance at Dec. 31, 2018 $ 211,013 $ 169,123 87,180,165 (25,575,808) (220,032) 61,764,461
Balance, shares at Dec. 31, 2018 211,013,043 97,136        
Sales of common stock   $ 800 2,599,200 $ 2,600,000
Sales of common stock, shares   799,995       799,995
Issuance of subscribed shares $ 97 $ (169,123) 169,026
Issuance of subscribed shares, shares 97,136 (97,136)        
Exercise of options $ 417 $ 413,894 11,189 425,500
Exercise of options, shares 417,352 2,644,456        
Exercise of warrants $ 686 611,756 612,442
Exercise of warrants, shares 686,104        
Distributions (376,993) (376,993)
MediTaurus acquisition $ 2,080,000 1,200,000 3,280,000
MediTaurus acquisition, shares 752,260        
Terrace investment $ 500 1,589,500 1,590,000
Terrace investment, shares 500,000        
Harvest payment $ 1,000 (1,000)
Harvest payment, shares 1,000,000        
Amortization of stock grants $ 109 193,601 193,710
Amortization of stock grants, shares 108,820        
Amortization of option grants 1,219,958 1,219,958
Amortization of stand-alone warrant issuances 139,015 139,015
Warrant discount on promissory notes 600,621 600,621
Warrant discount on debentures payable 1,148,056 1,148,056
Beneficial conversion feature on debentures payable 4,235,469 4,235,469
Conversion of debentures payable $ 3,592 $ 2,464,438 5,391,253 7,859,283
Conversion of debentures payable, shares 3,591,523 3,206,816        
Net income (loss) (2,744,808) 246,367 (2,498,441)
Balance at Sep. 30, 2019 $ 218,214 $ 4,958,332 $ 105,087,809 $ (28,320,616) $ 849,342 $ 82,793,081
Balance, shares at Sep. 30, 2019 218,213,973 6,603,532